Effects of Qishen Yiqi dropping pills plus conventional Western medicine on cardiac function and quality of life of patients with chronic heart failure

Aim: To assess the impact of combining Qishen Yiqi dropping pills (QSYQ) with conventional Western medicine on the cardiac function and quality of life in patients with chronic heart failure (CHF). Methods: This was a randomized controlled trial (RCT), and 120 patients with CHF were recruited and randomly divided into the control group (receiving conventional Western medicine treatment) and study group (receiving QSYQ and conventional Western medicine treatment) at 1:1 ratio. The primary outcome was clinical efficacy, and the secondary outcomes were cardiac function, exercise tolerance, quality of life, inflammatory markers, and adverse reactions. Results: = 0.542). Conclusion: QSYQ combined with conventional Western medicine yielded a notable therapeutic effect on CHF, indicating that QSYQ may be an important adjuvant therapy for CHF patients.